Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo illustration: Aïda Amer/Axios. Photo: Joe Raedle/Getty Images

The coronavirus is not only a life-or-death crisis that will be waiting for President-elect Joe Biden on Day One. It’s a crisis that will keep getting worse every day, making it harder and harder for a new administration to solve.

The big picture: The virus will not know there’s a new president. It will simply keep spreading, and killing people, until we stop it. The challenge of stopping it will be Biden’s first, most urgent order of business. And it will be incredibly difficult.

The U.S. is on a very bad trajectory, at a high-risk time. The virus will likely continue to spread largely unchecked all winter, right through to Inauguration Day and beyond.

  • As our weekly map shows, new coronavirus infections jumped by 40% over the past week, and the daily average — roughly 119,000 new cases per day — is by far the highest of any point in the pandemic.
  • And even if the pace of new infections slows down at some point, the U.S. has never managed to actually control the virus. 120,000 cases a day is a nightmare, but 60,000 was also considered too many.

Biden will have to manage an enormously complicated behind-the-scenes response, but his biggest challenge will be to get the public to take advantage of that response.

  • His administration will face no greater imperative in its first days than to bring sidelined career officials back into the fold, untangle the Trump administration’s processes and reorient the country’s health agencies, even as it will still be staffing up those agencies.
  • And the complicated logistics of distributing vaccines will likely be ramping up just as the White House changes hands, further raising the stakes for a smooth transition.

The bad news: There won’t be a lot Biden can do right away to turn things around.

  • More testing would help, but testing alone doesn’t control the spread of the virus. Financial aid to make it easier for high-risk people to stay home would also help, but that will be a tough fight in a divided government.
  • What the U.S. needs, most of all, is to start taking the virus seriously and adopting the measures that control its spread.
  • Biden has been clear about his intent to try to lead by example. But in a country where every aspect of the pandemic has already become a partisan flashpoint, and where governors control most of the decisions about what’s open or closed, his hands will be tied.

The good news: The scientists and researchers working on treatments and vaccines are moving with record speed around the world. They’ve already made enormous progress, and will be even further along by early next year.

  • If the early results from Pfizer’s vaccine trial hold, and the rest of the process moves smoothly, the distribution of that vaccine would likely get going early next year and continue to ramp up from there.
  • Hopefully, additional vaccines will also yield promising results and could also become available next spring.

The catch: As Axios has been trying to warn you, a vaccine will not be a silver bullet and will not immediately end the pandemic.

  • Pfizer estimates it will have enough product at the end of this year to vaccinate about 25 million Americans. High-risk groups will get the first doses; it’ll be well into 2021, at the absolute earliest, before the general public starts getting access.
  • It’ll ultimately be the government’s job to manage that process — and to persuade people to get vaccinated, once they have the opportunity.
  • Existing anti-vaccine misinformation, coupled with good-faith questions about such an incredibly fast process, mixed with partisan attitudes toward the virus and the tools to fight it, could make it that much harder to eventually move past this pandemic.

The bottom line: COVID-19 is killing over 800 Americans per day, on average. At that rate, nearly 60,000 people would die between now and Inauguration Day.

Go deeper:

Coronavirus cases rise by 40%

Go deeper

Jan 29, 2021 - Health

J&J says its one-shot vaccine is 66% effective against moderate to severe COVID

Photo: Thiago Prudêncio/SOPA Images/LightRocket via Getty Images

Johnson & Johnson announced Friday that its single-shot coronavirus vaccine was 66% effective in protecting against moderate to severe COVID-19 disease in Phase 3 trials, which was comprised of nearly 44,000 participants across eight countries.

Between the lines: The vaccine was 72% effective in the U.S., but only 57% effective in South Africa, where a more contagious variant has been spreading. It prevented 85% of severe infections and 100% of hospitalizations and deaths, according to the company.

Updated 4 hours ago - Politics & Policy

Omicron dashboard

Illustration: Aïda Amer/Axios

  1. Health: WHO says Omicron poses "very high" risk — Fauci says Omicron variant will "inevitably" be found in U.S. — U.S. restricts air travel from 8 countries over Omicron concerns.
  2. Politics: Biden says fight against Omicron won't include "shutdowns or lockdowns."
  3. States: New York declares state of emergency amid concerns over Omicron.
  4. World: Omicron adds urgency to vaccinating worldWHO warns against travel bans on southern African countries — First North American Omicron cases identified in Canada.
  5. Variant tracker: Where different strains are spreading.
Jan 29, 2021 - Health

WHO says most pregnant women can now receive coronavirus vaccine

A doctor administering Moderna's coronavirus vaccine at a university hospital in Essen, Germany, on Jan. 18. Photo: Lukas Schulze/Getty Images

The World Health Organization has altered its guidance for pregnant women who wish to receive the coronavirus vaccine, saying now that those at high risk of exposure to the COVID-19 or who have comorbidities that increase their risk of severe disease, may be vaccinated.

Why it matters: The WHO drew backlash for its previous guidance that did not recommend pregnant women be inoculated with vaccines made by Pfizer-BioNTech or Moderna, even though data indicated that pregnancy increased the risk of developing severe illness from the virus.